Blunted erythropoietin response to anemia in patients with Type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 16, Issue 3, 2000, Pages 172-176

  Cotroneo, Patrizia ^a   Ricerca, Bianca Maria ^a   Todaro, Lucia ^a   Pitocco, Dario ^a   Manto, Andrea ^a   Ruotolo, Valeria ^a   Storti, Sergio ^a   Damiani, Patrizia ^a   Caputo, Salvatore ^a   Ghirlanda, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Anemia; Autonomic neuropathy; Erythropoietin; Insulin dependent diabetes; Nephropathy

Indexed keywords

ALBUMIN; CREATININE; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEMOGLOBIN A1C; IRON;

ADULT; ANEMIA; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD CELL COUNT; BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON BLOOD LEVEL; KIDNEY FAILURE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANEMIA; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED;

EID: 0034130547     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-7560(200005/06)16:3<172::AID-DMRR117>3.0.CO;2-D     Document Type: Article

References (31)

1. Bear AN, Dessypris EN, Goldwasser E, Krantz SB. Blunted erythropoietin to anemia in rheumatoid arthritis. Br J Haematol 1987; 66: 559-564.
2. Miller CB, Jones RJ, Piandosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990; 322: 1689-1692.
3. Schreiber S, Howaaldt S, Schnor M, Raedler A. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334: 619-623.
4. Matthews MR. Autonomie ganglia in multiple system atrophy and pure autonomie failure. In Autonomie Failure. A Textbook of Disorders of the Autonomie Nervous System (3rd edn), Bannister R, Mathias CJ (eds). Oxford University Press: Oxford, 1992; 593-621.
5. Hoeldtke RD, Streeten HP, Phil D. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329: 611-615.
6. Kojima K, Totsuka Y. Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients. Diabetes Res Clin Pract 1995; 27: 229-233.
7. Spivak JL. Physiology and clinical application of erytrhopoietin. Hematol Rev 1993; 7: 203-205.
8. Cotroneo P, Manto A, Todaro L, Manto A Jr, Pitocco D, Saponara C, Vellante C, Maussier ML, D'Errico G, Magnani P, Ghirlanda G. Hyperfiltration in patients with type I diabetes mellitus: a prevalence study. Clin Nephrol 1998; 4: 214-217.
9. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.
10. Cazzola M, Beguin Y. New tools for clinical evaluation of eritroid function in man. Br J Haematol 1992; 80: 278-284.
11. Kallab AM, Dabaghian G, Terjanian T. Anemia secondary to low erythropoietin in a patient with normal renal function. Mt Sinai J Med 1987; 64: 406-408.
12. Rarick MU, Espina BM, Colley DT, Chrusoskie A, Gandara S, Feinstein DI. Treatment of a unique anemia in patients with IDDM with epoietin alfa. Diabetes Care 1998; 21: 423-426.
13. Winkler AS, Mardsen J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 1999; 16: 813-819.
14. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoppe W, Koch KM. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54: 877-884.
15. Chandra M, Clemons GK, McVicar MI. Relation of serum erythropoietin levels to renal excretory function: evidence of a lowered set point for erythropoietin production in chronic renal failure. J Pediatr 1988; 113: 312-315.
16. Inomata S, Itoh M, Imai H, Sato T. Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997; 75: 426-430.
17. Lane HL, Steffer W, Fioretto P, Mauer SM. Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993; 43: 661-667.
18. Fine LG, Ong ACM, Norman JT. Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993; 23: 259-265.
19. Lacombe C, Da Silva JL, Brunneval P, Fournier JG, Wendling F, Casadevall N, et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest 1988; 81: 620-623.
20. Backmann S, Hir M, Eckardt KU. Co-localization of erythropoietin mRNA end ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993; 41: 335-341.
21. Maxwell PH, Osmond MK, Puch CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44: 1149-1162.
22. Inomata S, Nakamoto Y, Inoue M, Itoh M, Ohsawa Y, Masamune O. Relationship between urinary albumin excretion rate and renal histology in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1989; 3: 172-178.
23. Biaggioni I, Robertson D, Krantz, Jones M, Haile V. The anemia of primary autonomie failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994; 121: 181-186.
24. Spannahake EW, Fisher JW. Partial inhibition of hypoxia induced erythropoietin production by cholinergic blockade in the dog. Proc Soc Exp Biol Med 1977; 156: 19-23.
25. Fink GD, Paulo LG, Fisher JW. Effects of beta adrenergic blocking agents on erythropoiesis in rabbit exposed to hypoxia. J Pharmacol Exp Ther 1975; 193: 176-181.
26. Fink GD, Fisher JW. Stimulation of erythropoiesis by beta adrenergic agonists. Mechanism of action. J Pharmacol Exp Ther 1977; 202: 199-208.
27. Zivny J, Ostadal B, Neuwirt J, Prochazka J, Pelouch V. Effect of beta adrenergic blocking agents on erythropoiesis in rats. J Pharmacol Exp Ther 1983; 226: 222-225.
28. Bertero MT, Caligaris-Cappio F. Anemia of chronic disorders in systemic autoimmune disease. Haematologica 1997; 82: 375-381.
29. Davis D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ. Anemia of chronic disease in rheumatoid arthritis: in vivo effects of tumor necrosis factor and blockade. Br J Rheumatol 1997; 36: 950-956.
30. Gould AB, Goodman SA, de Wolf R, Onesti G, Swartz C. Interrelation of renin system and erythropoietin in rats. J Lab Clin Med 1980; 96: 523-534.
31. Pratt MC, Lewis-Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J. Effects of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992; 34: 363-365.